Emerson Auditorium, Bauer Hall, Charles F. Knight Center
Scott Hollister, PhD will present.
Professor and Patsy and Alan Dorris Chair in Pediatric Technology
Wallace H. Coulter Dept. of Biomedical Engineering
Georgia Institute of Technology and Emory University
Abstract: Two technical advances over the past 10-15 years have made the capability to create medical devices from the academic setting a reality. First, it is now straightforward to read patient image data as the basis for designing a patient device and to further simulate the behavior of that device in the patient. Second, there is increasing capability to 3D print that device from a variety of biomaterials including titanium alloy, PolyEtherEtherKetone (PEEK), PolyEtherKetoneKetone (PEKK), and Polycaprolactone (PCL) among others. 3D printing makes it feasible to create patient specific devices for niche patient markets due to the significantly lower manufacturing costs compared to traditional methods. Addressing such niche markets will likely increasingly fall to academic medical centers and biomedical engineering departments. However, such going down this path raises a number of challenges outside the typical academic endeavors. First and foremost is the need to address regulatory and design/quality control concerns from the FDA. Developing research that can be published and compete for extramural funding while being developed within design/quality control guidelines requires a balancing act, as research favors cutting edge complex ideas while clinical use favors established tried and true, simpler measures. This talk will highlight our own experience is addressing these conflicting issues for a patient specific 3D printed airway splint without getting lost in translation.